Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00608959Phase 3Completed
A Phase 3 trial of CLS001 topical gel vehicle in catheter infection, sponsored by Cadence Pharmaceuticals, Inc.. Started May 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00608959.